This week's highlights
In a week that saw technology stocks lead global markets lower, ETFS Ultra Short Nasdaq 100 Hedge Fund (SNAS) was the week’s overall top performing fund, up 8.3%. ETFS S&P Biotech ETF (CURE) gained 5.7% as global concerns over the Omicron variant intensified. Mining and resources funds (MNRS, OZR, GDX and QRE) and domestic property funds (VAP and SLF) were also amongst the top performers. Crypto-related funds DIGA and CRYP were the week’s poorest performing ETFs, followed by a range of technology and energy-related funds.
Total reported flows into domestically domiciled ETFs were $351m, while outflows totalled $123m. The largest inflows for the week were into broad-based global equity fund IWLD, followed by cash fund AAA. Australian equity fund IOZ saw the largest outflows for the week.
VAS was the most traded fund for the week, followed by AAA.
ETFS S&P Biotech ETF (CURE) offers investors exposure to U.S. healthcare biotechnology companies. To be eligible for inclusion in the index, companies must be part of the biotechnology sub-industry of the U.S. healthcare sector and meet minimum market capitalisation and liquidity requirements.